Additional file 1 of Genomic and phenotypic characterisation of invasive neonatal and colonising group B Streptococcus isolates from Slovenia, 2001–2018
Creators: name: Perme, Tina
name: Golparian, Daniel
name: Ihan, Maja Bombek
name: Rojnik, Andrej
name: Lučovnik, Miha
name: Cerar, Lilijana Kornhauser
name: Fister, Petja
name: Krivec, Jana Lozar
name: Štefan Grosek
name: Ihan, Alojz
name: Jeverica, Samo
name: Unemo, Magnus
Publisher: name: figshare
Year: 2020
Subjects: subject: Space Science
subject: Medicine
subject: Microbiology
subject: FOS: Biological sciences
subject: FOS: Biological sciences
subject: Genetics
subject: Molecular Biology
subject: 59999 Environmental Sciences not elsewhere classified
subject: FOS: Earth and related environmental sciences
subject: FOS: Earth and related environmental sciences
subject: 39999 Chemical Sciences not elsewhere classified
subject: FOS: Chemical sciences
subject: FOS: Chemical sciences
subject: Ecology
subject: Science Policy
subject: 69999 Biological Sciences not elsewhere classified
subject: Cancer
subject: 110309 Infectious Diseases
subject: FOS: Health sciences
subject: FOS: Health sciences

description: Supplementary Table 1. Number of births in Slovenia during the years 2002–2018 and calculated representativeness of the sample based on the estimated incidence of invasive neonatal disease (IND) of 0.7/1000 births from reference 3. Supplementary Table 2. Antimicrobial susceptibility of Slovenian invasive neonatal and colonising pregnant women isolates of group B Streptococcus from early (2001–2011) and late (2012–2018) period (n = 171). Supplementary Table 3. Pairwise comparison of conventional phenotypic serotyping and molecular ‘serotyping’ results among invasive and non-invasive isolates of group B Streptococcus from early (2001–2011) and late (2012–2018) period (n = 171). Supplementary Table 4. Distribution of multilocus sequence typing (MLST) sequence types (STs) and clonal complexes (CCs) among Slovenian group B Streptococcus isolates overall and among isolates from infants with invasive neonatal disease (2001–2018) and pregnant woman with colonisation (2018. Supplementary Table 5. Distribution of multilocus sequence typing (MLST) and clonal complexes (CCs) among Slovenian group B Streptococcus isolates overall and among isolates from patients with invasive neonatal disease (2001–2018) and pregnant woman with colonisation (2018). Supplementary Table 6. Distribution of multilocus sequence typing (MLST) and clonal complexes (CCs) among invasive neonatal group B Streptococcus isolates from Slovenia within two groups based on disease onset. Supplementary Table 7. Distribution of multilocus sequence typing (MLST) and clonal complexes (CCs) among invasive neonatal group B Streptococcus isolates from Slovenia within two groups based on time period of disease. Supplementary Fig. 1. Distribution of invasive group B Streptococcus isolates (n = 114) from different laboratories in Slovenia from 2001 to 2018. Unfortunately, during 2001–2010, isolates from the largest laboratory (in Ljubljana) were not preserved so whole genome sequencing of those could not be performed. LJ: Ljubljana; MB: Maribor; CE: Celje; KP: Koper. Supplementary Fig. 2. eBURST analysis of 28 multilocus sequence typing (MLST) sequence types (STs) identifying six clonal complexes (CCs) and four singletons, among Slovenian group B Streptococcus isolates from infants with invasive neonatal disease (2001–2018) and pregnant woman with colonisation (2018).